{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:15:11Z","timestamp":1783350911691,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89794","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:33:10Z","timestamp":1754915590000},"source":"Crossref","is-referenced-by-count":5,"title":["Novel Biomarkers and Advanced Imaging in Cardiovascular Risk Stratification for Rheumatic Diseases"],"prefix":"10.7759","author":[{"given":"Freya H","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu C","family":"Tated","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshilkumar","family":"Maheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2022.07.004","article-title":"Atherosclerotic cardiovascular risk stratification in the rheumatic diseases:: an integrative, multiparametric approach","volume":"49","author":"Misra DP","year":"2023","unstructured":"Misra DP, Hauge EM, Crowson CS, Kitas GD, Ormseth SR, Karpouzas GA. Atherosclerotic cardiovascular risk stratification in the rheumatic diseases:: an integrative, multiparametric approach. Rheum Dis Clin North Am. 2023, 49:19-43. 10.1016\/j.rdc.2022.07.004","journal-title":"Rheum Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos GC","year":"2022","unstructured":"Drosos GC, Vedder D, Houben E, et al.. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022, 81:768-779. 10.1136\/annrheumdis-2021-221733","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00989-w","article-title":"Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation","volume":"7","author":"Skeoch S","year":"2017","unstructured":"Skeoch S, Cristinacce PL, Williams H, et al.. Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. Sci Rep. 2017, 7:827. 10.1038\/s41598-017-00989-w","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2017.04.008","article-title":"A rare case of acute myocardial infarction with a non-specific symptom in a young female with systemic lupus erythematosus","volume":"16","author":"Komaki T","year":"2017","unstructured":"Komaki T, Miura SI, Gondo K, Nakamura A, Ike A, Matsunaga A, Saku K. A rare case of acute myocardial infarction with a non-specific symptom in a young female with systemic lupus erythematosus. J Cardiol Cases. 2017, 16:56-61. 10.1016\/j.jccase.2017.04.008","journal-title":"J Cardiol Cases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.07.010","article-title":"Rheumatoid arthritis and cardiovascular disease","volume":"166","author":"Crowson CS","year":"2013","unstructured":"Crowson CS, Liao KP, Davis JM 3rd, et al.. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013, 166:622-628.e1. 10.1016\/j.ahj.2013.07.010","journal-title":"Am Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld Y","year":"2005","unstructured":"Shoenfeld Y, Gerli R, Doria A, et al.. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005, 112:3337-3347. 10.1161\/CIRCULATIONAHA.104.507996","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226812","article-title":"Associations between cardiovascular outcomes and rheumatoid arthritis: a nationwide population-based cohort study","volume":"11","author":"Kang S","year":"2022","unstructured":"Kang S, Han K, Jung JH, et al.. Associations between cardiovascular outcomes and rheumatoid arthritis: a nationwide population-based cohort study. J Clin Med. 2022, 11:6812. 10.3390\/jcm11226812","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcreu.2021.03.002","article-title":"Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus","volume":"28","author":"Quintana R","year":"2021","unstructured":"Quintana R, Pons-Estel GJ, Serrano R, Pons-Estel BA, Bruce IN. Accelerated atherosclerosis and cardiovascular disease in systemic lupus erythematosus. Revista Colombiana de Reumatolog\u00eda. 2021, 28:21-30. 10.1016\/j.rcreu.2021.03.002","journal-title":"Revista Colombiana de Reumatolog\u00eda"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.07.001","article-title":"C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis","volume":"104","author":"Erre GL","year":"2022","unstructured":"Erre GL, Cacciapaglia F, Sakellariou G, et al.. C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis. Eur J Intern Med. 2022, 104:49-54. 10.1016\/j.ejim.2022.07.001","journal-title":"Eur J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/life13020319","article-title":"Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy","volume":"13","author":"Popescu D","year":"2023","unstructured":"Popescu D, Rezus E, Badescu MC, Dima N, Seritean Isac PN, Dragoi IT, Rezus C. Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy. Life (Basel). 2023, 13:319. 10.3390\/life13020319","journal-title":"Life (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.127704","article-title":"NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study","volume":"69","author":"Provan S","year":"2010","unstructured":"Provan S, Angel K, Semb AG, Atar D, Kvien TK. NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study. Ann Rheum Dis. 2010, 69:1946-1950. 10.1136\/ard.2009.127704","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/970394","article-title":"N-terminal proBNP levels and tissue Doppler echocardiography in acute rheumatic carditis","volume":"2013","author":"Kotby AA","year":"2013","unstructured":"Kotby AA, El-Shahed GS, Elmasry OA, El-Hadidi IS, El Shafey RN. N-terminal proBNP levels and tissue Doppler echocardiography in acute rheumatic carditis. ISRN Pediatr. 2013, 2013:970394. 10.1155\/2013\/970394","journal-title":"ISRN Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/app15031590","article-title":"Update: Heart failure in systemic lupus erythematosus","volume":"15","author":"Blachut D","year":"2025","unstructured":"Blachut D, Mazurkiewicz M, Schulz M, Cie\u015bla J, Przywara-Chowaniec B, Tomasik A. Update: Heart failure in systemic lupus erythematosus. Appl Sci. 2025, 15:1590. 10.3390\/app15031590","journal-title":"Appl Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281155","article-title":"High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis","volume":"18","author":"Nguyen TH","year":"2023","unstructured":"Nguyen TH, Fagerland MW, Hollan I, Whist JE, Feinberg MW, Agewall S. High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis. PLoS One. 2023, 18:e0281155. 10.1371\/journal.pone.0281155","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/jesnt.jesnt_27_20","article-title":"Biomarkers of myocardial injury in lupus nephritis","volume":"21","author":"Ibrahim MET","year":"2021","unstructured":"Ibrahim MET, EIshahawy EML, Mahmoud AT, Nasr RS, Mansour AE. Biomarkers of myocardial injury in lupus nephritis. J Egypt Soc Nephrol Transplant. 2021, 21:80-90. 10.4103\/jesnt.jesnt_27_20","journal-title":"J Egypt Soc Nephrol Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038930","article-title":"High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation","volume":"7","author":"Bradham WS","year":"2012","unstructured":"Bradham WS, Bian A, Oeser A, et al.. High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation. PLoS One. 2012, 7:e38930. 10.1371\/journal.pone.0038930","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.07.005","article-title":"Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases","volume":"264","author":"Damen MS","year":"2017","unstructured":"Damen MS, Popa CD, Netea MG, Dinarello CA, Joosten LA. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases. Atherosclerosis. 2017, 264:83-91. 10.1016\/j.atherosclerosis.2017.07.005","journal-title":"Atherosclerosis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/srep41629","article-title":"IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis","volume":"7","author":"Damen MS","year":"2017","unstructured":"Damen MS, Agca R, Holewijn S, et al.. IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis. Sci Rep. 2017, 7:41629. 10.1038\/srep41629","journal-title":"Sci Rep"},{"key":"ref19","article-title":"Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis","volume":"31","author":"Gui M","year":"2012","unstructured":"Gui M, Zhang H, Zhong K, Li Y, Sun J, Wang L. Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis. Asian Pac J Allergy Immunol. 2012, 31:73-78.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312612","article-title":"Dkk (Dickkopf) proteins: emerging new players in atherosclerosis","volume":"39","author":"Baetta R","year":"2019","unstructured":"Baetta R, Banfi C. Dkk (Dickkopf) proteins: emerging new players in atherosclerosis. Arterioscler Thromb Vasc Biol. 2019, 39:1330-1342. 10.1161\/ATVBAHA.119.312612","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189910","article-title":"Enhanced association of novel cardiovascular biomarkers fetuin-A and catestatin with serological and inflammatory markers in rheumatoid arthritis patients","volume":"25","author":"P\u00e0mies A","year":"2024","unstructured":"P\u00e0mies A, Llop D, Ibarretxe D, et al.. Enhanced association of novel cardiovascular biomarkers fetuin-A and catestatin with serological and inflammatory markers in rheumatoid arthritis patients. Int J Mol Sci. 2024, 25:9910. 10.3390\/ijms25189910","journal-title":"Int J Mol Sci"},{"key":"ref22","article-title":"Galectin-3 may be a biomarker for cardiovascular disease in RA","author":"Stanton C","year":"2023","unstructured":"Stanton C. Galectin-3 may be a biomarker for cardiovascular disease in RA. Rheumatologist. 2023,","journal-title":"Rheumatologist"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040870","article-title":"New cardiovascular risk biomarkers in rheumatoid arthritis: implications and clinical utility-A narrative review","volume":"13","author":"Pamies A","year":"2025","unstructured":"Pamies A, Vallv\u00e9 JC, Paredes S. New cardiovascular risk biomarkers in rheumatoid arthritis: implications and clinical utility-A narrative review. Biomedicines. 2025, 13:870. 10.3390\/biomedicines13040870","journal-title":"Biomedicines"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70028","article-title":"Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients","volume":"28","author":"Roghani SA","year":"2024","unstructured":"Roghani SA, Shamsi A, Jalili C, et al.. Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients. J Cell Mol Med. 2024, 28:e70028. 10.1111\/jcmm.70028","journal-title":"J Cell Mol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00177","article-title":"Targeting inflammation to prevent cardiovascular disease in chronic rheumatic diseases: myth or reality?","volume":"5","author":"Bartoloni E","year":"2018","unstructured":"Bartoloni E, Alunno A, Valentini V, et al.. Targeting inflammation to prevent cardiovascular disease in chronic rheumatic diseases: myth or reality?. Front Cardiovasc Med. 2018, 5:177. 10.3389\/fcvm.2018.00177","journal-title":"Front Cardiovasc Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcdr.2012.09.003","article-title":"Anti-CCP antibody in patients with established rheumatoid arthritis: does it predict adverse cardiovascular profile?","volume":"4","author":"Arnab B","year":"2013","unstructured":"Arnab B, Biswadip G, Arindam P, Shyamash M, Anirban G, Rajan P. Anti-CCP antibody in patients with established rheumatoid arthritis: does it predict adverse cardiovascular profile?. J Cardiovasc Dis Res. 2013, 4:102-106. 10.1016\/j.jcdr.2012.09.003","journal-title":"J Cardiovasc Dis Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032095","article-title":"Biomarkers of cardiovascular risk in patients with rheumatoid arthritis: results from the TARGET trial","volume":"13","author":"Solomon DH","year":"2024","unstructured":"Solomon DH, Demler O, Rist PM, et al.. Biomarkers of cardiovascular risk in patients with rheumatoid arthritis: results from the TARGET trial. J Am Heart Assoc. 2024, 13:e032095. 10.1161\/JAHA.123.032095","journal-title":"J Am Heart Assoc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296459","article-title":"External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"19","author":"Sasso EH","year":"2024","unstructured":"Sasso EH, Mabey B, Flake DD 2nd, et al.. External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis. PLoS One. 2024, 19:e0296459. 10.1371\/journal.pone.0296459","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315588577","article-title":"Imaging of cardiovascular complications in patients with systemic lupus erythematosus","volume":"24","author":"Lin K","year":"2015","unstructured":"Lin K, Lloyd-Jones DM, Li D, Liu Y, Yang J, Markl M, Carr JC. Imaging of cardiovascular complications in patients with systemic lupus erythematosus. Lupus. 2015, 24:1126-1134. 10.1177\/0961203315588577","journal-title":"Lupus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2017.02.001","article-title":"Prognostic role of subclinical left ventricular systolic dysfunction evaluated by speckle-tracking echocardiography in rheumatoid arthritis","volume":"30","author":"Cioffi G","year":"2017","unstructured":"Cioffi G, Viapiana O, Ognibeni F, et al.. Prognostic role of subclinical left ventricular systolic dysfunction evaluated by speckle-tracking echocardiography in rheumatoid arthritis. J Am Soc Echocardiogr. 2017, 30:602-611. 10.1016\/j.echo.2017.02.001","journal-title":"J Am Soc Echocardiogr"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.011","article-title":"Carotid plaques as predictors of cardiovascular events in patients with rheumatoid arthritis. Results from a 5-year-prospective follow-up study","volume":"50","author":"Corrales A","year":"2020","unstructured":"Corrales A, Vegas-Revenga N, Rueda-Gotor J, et al.. Carotid plaques as predictors of cardiovascular events in patients with rheumatoid arthritis. Results from a 5-year-prospective follow-up study. Semin Arthritis Rheum. 2020, 50:1333-1338. 10.1016\/j.semarthrit.2020.03.011","journal-title":"Semin Arthritis Rheum"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72675","article-title":"Diagnostic value of cardiac magnetic resonance imaging (CMRI) in the evaluation of arrhythmia and cardiomyopathy","volume":"16","author":"Singh RP","year":"2024","unstructured":"Singh RP, Singh P, Kler TS, Sharma SM. Diagnostic value of cardiac magnetic resonance imaging (CMRI) in the evaluation of arrhythmia and cardiomyopathy. Cureus. 2024, 16:e72675. 10.7759\/cureus.72675","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-11282-6","article-title":"Diagnostic and prognostic value of quantitative cardiac magnetic resonance imaging biomarkers in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"35","author":"Azoulay LD","year":"2025","unstructured":"Azoulay LD, Kachenoura N, Boussouar S, et al.. Diagnostic and prognostic value of quantitative cardiac magnetic resonance imaging biomarkers in systemic lupus erythematosus: a systematic review and meta-analysis. Eur Radiol. 2025, 35:3858-3870. 10.1007\/s00330-024-11282-6","journal-title":"Eur Radiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1215907","article-title":"Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases","volume":"10","author":"Gulhane A","year":"2023","unstructured":"Gulhane A, Ordovas K. Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases. Front Cardiovasc Med. 2023, 10:1215907. 10.3389\/fcvm.2023.1215907","journal-title":"Front Cardiovasc Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeac134","article-title":"Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging","volume":"23","author":"Mavrogeni S","year":"2022","unstructured":"Mavrogeni S, Pepe A, Nijveldt R, et al.. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022, 23:e308-e322. 10.1093\/ehjci\/jeac134","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2024.100623","article-title":"Differences in myocardial involvement between new onset and longstanding systemic lupus erythematosus patients assessed by cardiovascular magnetic resonance","volume":"14","author":"Wang Z","year":"2025","unstructured":"Wang Z, Tang X, Hang C, et al.. Differences in myocardial involvement between new onset and longstanding systemic lupus erythematosus patients assessed by cardiovascular magnetic resonance. Eur J Radiol Open. 2025, 14:100623. 10.1016\/j.ejro.2024.100623","journal-title":"Eur J Radiol Open"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-4838-4","article-title":"Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis","volume":"27","author":"Greulich S","year":"2017","unstructured":"Greulich S, Mayr A, Kitterer D, et al.. Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis. Eur Radiol. 2017, 27:4639-4649. 10.1007\/s00330-017-4838-4","journal-title":"Eur Radiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping","volume":"8","author":"Ntusi NA","year":"2015","unstructured":"Ntusi NA, Piechnik SK, Francis JM, et al.. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015, 8:526-536. 10.1016\/j.jcmg.2014.12.025","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2010.11.007","article-title":"Coronary microvascular dysfunction in systemic lupus erythematosus identified by CMR imaging","volume":"4","author":"Pennell DJ","year":"2011","unstructured":"Pennell DJ, Keenan NG. Coronary microvascular dysfunction in systemic lupus erythematosus identified by CMR imaging. JACC Cardiovasc Imaging. 2011, 4:34-36. 10.1016\/j.jcmg.2010.11.007","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref40","article-title":"Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities","volume":"27","author":"Bruce IN","year":"2000","unstructured":"Bruce IN, Burns RJ, Gladman DD, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J Rheumatol. 2000, 27:2372-2377.","journal-title":"J Rheumatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S251168","article-title":"Rheumatoid arthritis as a risk factor for coronary artery calcification and obstructive coronary artery disease in patients with chest pain: a registry based cross-sectional study","volume":"12","author":"Tinggaard AB","year":"2020","unstructured":"Tinggaard AB, de Thurah A, Andersen IT, et al.. Rheumatoid arthritis as a risk factor for coronary artery calcification and obstructive coronary artery disease in patients with chest pain: a registry based cross-sectional study. Clin Epidemiol. 2020, 12:679-689. 10.2147\/CLEP.S251168","journal-title":"Clin Epidemiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70517","article-title":"Coronary artery calcification in rheumatoid arthritis patients: a systematic review","volume":"16","author":"Nagy S","year":"2024","unstructured":"Nagy S, Ditchek J, Kesselman MM. Coronary artery calcification in rheumatoid arthritis patients: a systematic review. Cureus. 2024, 16:e70517. 10.7759\/cureus.70517","journal-title":"Cureus"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3892\/mi.2024.176","article-title":"Cardiovascular risk markers (computed tomography\u2011coronary artery calcium and carotid intima\u2011media thickness) in patients with rheumatoid arthritis and controls","volume":"4","author":"Fatima J","year":"2024","unstructured":"Fatima J, Shukla V, Siddiqi Z, Shamsi MZ, Mateen S, Jabbar AA, Usmani Z. Cardiovascular risk markers (computed tomography\u2011coronary artery calcium and carotid intima\u2011media thickness) in patients with rheumatoid arthritis and controls. Med Int (Lond). 2024, 4:52. 10.3892\/mi.2024.176","journal-title":"Med Int (Lond)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.601344","article-title":"Largely accelerated arterial aging in rheumatoid arthritis is associated with inflammatory activity and smoking in the early stage of the disease","volume":"11","author":"Mong N","year":"2020","unstructured":"Mong N, Tarjanyi Z, Tothfalusi L, et al.. Largely accelerated arterial aging in rheumatoid arthritis is associated with inflammatory activity and smoking in the early stage of the disease. Front Pharmacol. 2020, 11:523962. 10.3389\/fphar.2020.601344","journal-title":"Front Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/art.40345","article-title":"Arterial inflammation detected with (18) F-fluorodeoxyglucose-positron emission tomography in rheumatoid arthritis","volume":"70","author":"Geraldino-Pardilla L","year":"2018","unstructured":"Geraldino-Pardilla L, Zartoshti A, Bag Ozbek A, et al.. Arterial inflammation detected with (18) F-fluorodeoxyglucose-positron emission tomography in rheumatoid arthritis. Arthritis Rheumatol. 2018, 70:30-39. 10.1002\/art.40345","journal-title":"Arthritis Rheumatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02585-w","article-title":"Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?","volume":"23","author":"Trang DA","year":"2021","unstructured":"Trang DA, Okamura K, Suto T, et al.. Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?. Arthritis Res Ther. 2021, 23:206. 10.1186\/s13075-021-02585-w","journal-title":"Arthritis Res Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2019.11.009","article-title":"PET scan with fludeoxyglucose\/computed tomography in low-grade vascular inflammation","volume":"15","author":"Reddy AS","year":"2020","unstructured":"Reddy AS, Uceda DE, Al Najafi M, Dey AK, Mehta NN. PET scan with fludeoxyglucose\/computed tomography in low-grade vascular inflammation. PET Clin. 2020, 15:207-213. 10.1016\/j.cpet.2019.11.009","journal-title":"PET Clin"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092104","article-title":"Role of endomyocardial biopsy in diagnostics of myocarditis","volume":"12","author":"Vidusa L","year":"2022","unstructured":"Vidusa L, Kalejs O, Maca-Kaleja A, Strumfa I. Role of endomyocardial biopsy in diagnostics of myocarditis. Diagnostics (Basel). 2022, 12:2104. 10.3390\/diagnostics12092104","journal-title":"Diagnostics (Basel)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000265","article-title":"Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography","volume":"5","author":"Perel-Winkler A","year":"2018","unstructured":"Perel-Winkler A, Bokhari S, Perez-Recio T, Zartoshti A, Askanase A, Geraldino-Pardilla L. Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography. Lupus Sci Med. 2018, 5:e000265. 10.1136\/lupus-2018-000265","journal-title":"Lupus Sci Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.786776","article-title":"Cardiovascular risks and risk stratification in inflammatory joint diseases: a cross-sectional study","volume":"9","author":"Yagensky V","year":"2022","unstructured":"Yagensky V, Schirmer M. Cardiovascular risks and risk stratification in inflammatory joint diseases: a cross-sectional study. Front Med (Lausanne). 2022, 9:786776. 10.3389\/fmed.2022.786776","journal-title":"Front Med (Lausanne)"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2020.44","article-title":"Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment","volume":"16","author":"Kerola AM","year":"2021","unstructured":"Kerola AM, Rollefstad S, Semb AG. Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment. Eur Cardiol Rev. 2021, 16:e18.","journal-title":"Eur Cardiol Rev"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027846","article-title":"Sore, hot, and at risk: the emerging specialty of cardio-rheumatology","volume":"12","author":"Weber B","year":"2023","unstructured":"Weber B, Garshick M, Liao KP, Di Carli M. Sore, hot, and at risk: the emerging specialty of cardio-rheumatology. J Am Heart Assoc. 2023, 12:e027846. 10.1161\/JAHA.122.027846","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370670-novel-biomarkers-and-advanced-imaging-in-cardiovascular-risk-stratification-for-rheumatic-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:33:12Z","timestamp":1754915592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370670-novel-biomarkers-and-advanced-imaging-in-cardiovascular-risk-stratification-for-rheumatic-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.89794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}